IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Chronic Opioid Use in Rheumatoid Arthritis: Prevalence & Predictors
Tips for Interdisciplinary Pain Management in Older Patients
Clinicians’ Use of ‘Safer’ Opioid-Prescribing Practices Spotty
Tanezumab for OA Pain
Ibuprofen an Option for Early Pain Control after Hip Replacement
Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones
The Perils of Pain Meds Revisited
- 1
- 2
- 3
- …
- 13
- Next Page »